US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NYLI Merger Arbitrage ETF

36.65

+0.03000.08%

Post-market: 36.650.00000.00%16:15 EDT

Volume:31.83K

Turnover:1.17M

Market Cap:256.55M

PE:- -

High:36.85

Open:36.66

Low:36.48

Close:36.62

52wk High:37.19

52wk Low:34.91

Shares:7.00M

Float Shares:7.00M

Volume Ratio:1.53

T/O Rate:0.45%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Hardwyn India Boosts Authorised Share Capital After Shareholder Nod

Medicus Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Update

Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill

Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset

Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan

Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJect™ Dataset

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/MNA/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MNA\",,,,,undefined,":{"symbol":"MNA","market":"US","secType":"STK","nameCN":"NYLI Merger Arbitrage ETF","latestPrice":36.65,"timestamp":1788292800000,"preClose":36.62,"halted":0,"volume":31830,"hourTrading":{"tag":"盘后","latestPrice":36.65,"preClose":36.65,"latestTime":"16:15 EDT","volume":9,"amount":329.85,"timestamp":1788293700194,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0008192244675041272,"floatShares":7000000,"shares":7000000,"eps":0,"marketStatus":"Not Yet Opened","change":0.03,"latestTime":"09-01 16:00:00 EDT","open":36.66,"high":36.85,"low":36.48,"amount":1166803,"amplitude":0.010104,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788336000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":36.62,"sharesOutstanding":6950000,"nav":36.51869,"aum":255470969.41,"bidAskSpread":0.001192,"preHourTrading":{"tag":"盘前","latestPrice":36.62,"preClose":36.62,"latestTime":"07:37 EDT","volume":1,"amount":36.62,"timestamp":1788262671063,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":36.65,"preClose":36.65,"latestTime":"16:15 EDT","volume":9,"amount":329.85,"timestamp":1788293700194,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.525609,"impliedVol":0.2642,"impliedVolPercentile":0.8254},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MNA\",,,,,undefined,":{"symbol":"MNA","floatShares":7000000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.525609,"shares":7000000,"dividePrice":0,"high":36.85,"amplitude":0.010104,"preClose":36.62,"low":36.48,"week52Low":34.91,"pbRate":"--","week52High":37.19,"institutionHeld":0,"latestPrice":36.65,"eps":0,"divideRate":0,"volume":31830,"delay":0,"ttmEps":0,"open":36.66,"prevYearClose":35.79,"prevWeekClose":36.5861,"prevMonthClose":36.62,"prevQuarterClose":36.4795,"fiveDayClose":36.86,"twentyDayClose":36.6578,"sixtyDayClose":36.46},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MNA\",params:#limit:5,,,undefined,":[{"date":"2023-12-28","symbol":"MNA","amount":0.37752,"announcedDate":"2023-12-27","type":"dividend","market":"US","newRecordDate":"2023-12-29","defaultRemindTime":1703773800000,"name":"IQ ARB Merger Arbitrage ETF","recordDate":"2024-01-05","payableDate":"2023-12-29","currency":"USD","dateTimestamp":1703739600000,"payDate":"2024-01-05"},{"market":"US","date":"2020-12-30","symbol":"MNA","amount":0.76599,"name":"IQ ARB Merger Arbitrage ETF","recordDate":"2021-01-07","payableDate":"2020-12-31","currency":"USD","type":"dividend","dateTimestamp":1609304400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MNA\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-28","recordDate":"2016-12-30","paymentDate":"2017-01-04","value":0.06134,"currency":"USD"},{"executeDate":"2020-12-30","recordDate":"2020-12-31","paymentDate":"2021-01-07","value":0.76599,"currency":"USD"},{"executeDate":"2023-12-28","recordDate":"2023-12-29","paymentDate":"2024-01-05","value":0.37752,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MNA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MNA\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2648699587","title":"Hardwyn India Boosts Authorised Share Capital After Shareholder Nod","url":"https://stock-news.laohu8.com/highlight/detail?id=2648699587","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648699587?lang=en_us&edition=fundamental","pubTime":"2026-07-04 17:53","pubTimestamp":1783158818,"startTime":"0","endTime":"0","summary":"Hardwyn India Ltd. ( ($IN:HARDWYN) ) has provided an announcement. Hardwyn India Limited has secured shareholder approval at its first extra-ordina...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hardwyn-india-boosts-authorised-share-capital-after-shareholder-nod?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hardwyn-india-boosts-authorised-share-capital-after-shareholder-nod?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MNDmain","MNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635772644","title":"Medicus Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635772644","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635772644?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:30","pubTimestamp":1778790600,"startTime":"0","endTime":"0","summary":"Company Advances SkinJect and Teverelix Clinical Programs While Strengthening Financing Flexibility and Expanding Strategic Development InitiativesPHILADELPHIA, May  14, 2026  (GLOBE NEWSWIRE) -- Medi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/14/3295423/0/en/Medicus-Pharma-Reports-First-Quarter-2026-Financial-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MDCX","PD","LU1169589451.USD","BK4567","LABU","LU1169590202.USD","BK4104","BK4588","BCC","BK4585","MNA","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630395692","title":"Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill","url":"https://stock-news.laohu8.com/highlight/detail?id=2630395692","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630395692?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:30","pubTimestamp":1777289400,"startTime":"0","endTime":"0","summary":"Builds Support for Accelerated Access to SkinJect for Gorlin Syndrome patients with a Rare Autosomal Dominant DiseasePHILADELPHIA, April  27, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/27/3281511/0/en/Medicus-Pharma-CEO-meets-with-lawmakers-on-Energy-Commerce-Committee-on-Capitol-Hill.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCC","BK4023","BK4139","LU1169590202.USD","IND","PD","LU1169589451.USD","MNA","BK4567","MDCX","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624305518","title":"Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset","url":"https://stock-news.laohu8.com/highlight/detail?id=2624305518","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624305518?lang=en_us&edition=fundamental","pubTime":"2026-04-01 19:30","pubTimestamp":1775043000,"startTime":"0","endTime":"0","summary":"Provides guidance on interpretation of Topline dataset and confirms focus on drug-driven efficacy in non-melanoma skin cancerPHILADELPHIA, April  01, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/01/3266511/0/en/Medicus-Pharma-Ltd-Clarifies-Positive-SkinJect-Phase-2-Dataset.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSR","BK4023","LU1169590202.USD","LU1169589451.USD","BK4139","BK4215","MDCX","BK4567","PD","BCC","BK4104","MNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622852318","title":"Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2622852318","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622852318?lang=en_us&edition=fundamental","pubTime":"2026-03-26 19:30","pubTimestamp":1774524600,"startTime":"0","endTime":"0","summary":"200g Cohort at Day 57 Dataset suggests majority of treated Lesions may Avoid Surgery as Company targets larger unmet medical need in Non-melanoma Skin CancerPHILADELPHIA, March  26, 2026 (GLOBE NEWSWI","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/26/3262893/0/en/Medicus-Pharma-Business-Update-Call-to-Highlight-80-Overall-Response-Rate-ORR-in-Phase-2-SkinJect-Study-and-Agentic-AI-enabled-Drug-Development-Plan.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK4567","BK4213","BK4161","AGIX","BCC","MDCX","BK4215","LU1169589451.USD","AIPO","BK4104","CR","ORR","PR","MNA","CHAT","CSR","LU1169590202.USD","BK4139","PD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618662809","title":"Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJect™ Dataset","url":"https://stock-news.laohu8.com/highlight/detail?id=2618662809","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618662809?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:30","pubTimestamp":1773055800,"startTime":"0","endTime":"0","summary":"The Company Reported 73% Clinical Clearance in the 200-g cohort at Day 57PHILADELPHIA, March  09, 2026  (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (\"Medicus\" or the \"Company\"), a biotech/l","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/09/3251726/0/en/Medicus-Pharma-Provides-Interpretation-of-Positive-Phase-2-SkinJect-Dataset.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0170899867.USD","LU2237443622.USD","BCC","LU1935042991.SGD","LU2237443978.SGD","LU1935043023.USD","LU1066051225.USD","LU2420271590.USD","MDCX","LU1366192091.USD","LU2456880835.USD","LU1066053197.SGD","LU0053666078.USD","BK4139","LU1066051498.USD","LU2237443382.USD","LU2417539215.USD","LU1718418525.SGD","BK4567","LU1674673691.USD","LU2083900584.USD","LU0077335932.USD","LU0314104364.USD","LU1066051811.HKD","BK4104","LU1935042215.USD","LU1674673428.USD","APC","LU1366333091.USD","LU1935042488.USD","BK4214","LU0149725797.USD","MNA","LU0157215616.USD","LU2236285917.USD","LU1778281490.HKD","LU1496350171.SGD","LU0786609619.USD","LU1935043536.SGD","LU2237443549.SGD","LU0882574139.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":5,"totalSize":86,"code":"91000000","status":"200"}]}}